DGD Research - Leading the search for better health.
Current Research - Information on trials & testing
Study Opportunities - Learn how you can get involved
Healthy Living - Latest news on staying healthy
About DGD Research - Who we are and why we care

Publications & Abstracts

Abstracts

  • Prevalence of Co-Morbid Metabolic Abnormalities in Non-Diabetic Overweight/Obese Adults. Steven Weinstein, Catherine Vicary, Sherwyn Schwartz, Marshall Block, Barbara Tardiff. Abstract presented at the AACE, April 2004.
  • "Glucose Profiles in Patients Implanted with a Real-Time, Long-Term, Glucose Sensor." Steven V. Edelman, Sherwyn Schwartz, Satish K. Garg. San Diego, CA, San Antonio, TX Denver, CO. 63rd Scientific Sessions. Presented during Late Breaking Clinical Studies. - 06/15/2003.
  • "Insulin Plus Metformin vs. Triple Oral Therapy Following Failure of a Combination of 2 OAD's: Efficacy and Cost of Therapy." Priscilla Hollander; Sherwyn Schwartz; Richard Sievers; Poul Strange; Bob An; William Lyness; Dallas, TX; San Antonio, TX; Kettering, OH; Princeton Junction, NJ; Princeton, NJ. Diabetes: A Journal of The American Diabetes Association ®, A.D.A. Abstract Book, Volume 52, Supplement 1. June 14 to June 17, 2003.
  • "Response To Testosterone Supplementation With a New Topical Testosterone Gel (Testimä) in Older Men With Diabetes Mellitus." Sherwyn L. Schwartz; John P. Rodzvilla, Allen R. Secrest and Ted M. Smith². and Auxilium Pharmaceuticals, Inc., Norristown, PA, 19401. Presented at ENDO 2003 in Philadelphia, PA., June 2003.
  • "Symptoms of Low Testosterone Are a Strong Predictor of Hypogonadism." Sherwyn L. Schwartz¹*; John P. Rodzvilla², Allen R. Secrest and Ted M. Smith².

    ¹Diabetes and Glandular Disease Research Associates, P.A., San Antonio, TX, 78229 and ²Auxilium Pharmaceuticals, Inc., Norristown, PA, 19401. April 2003.

  • "Plasma Glucose and Insulin Response to Isocaloric Amounts of Enteral Formulas in Persons with Type 2 Diabetes Mellitus." S.L. Schwartz, M.D.; J. Fischer, M.D.; M. Kipnes, M.D. and L. Kelly, R.N. Diabetes and Glandular Disease Research Center, San Antonio, TX. January, 2003.
  • "Early Introduction of Oral Insulin in Patients Failing on Diet and Exercise, A Long-term Efficacy Study in Treatment of Type-2 Diabetes." Sherwyn Schwartz, M.D., Sherri Shade, R.N., Jayne Eaton, R.N., San Antonio, Texas; Pankaj Modi, M.D., Toronto CAN. June 2001.
  • "COMMUNITY SCREENING FOR DIABETES: SHOULD DEMOGRAPHICS BE A FACTOR?" Mark S. Kipnes, Sherwyn L. Schwartz, Jerome S. Fischer, William F. Trigoso, Amna A. Salhin, Jacob Vadakekalam, Daina Dreimane, William D. Linn. American Association of Clinical Endocrinologists 10th Annual Meeting & Clinical Congress. May 2-6, 2001. San Antonio, Texas.
  • Pharmacokinetics and Pharmacodynamics of Pulmonary Insulin Delivered Via The AERx Diabetes Management System in Type 1 Diabetes. Kipnes M, Otulana B, Okikawa J, Farr S, Jendle J, Thipphawong J, Schwartz S. Diabetologia 43 (Suppl. 1): A202, 2000.
  • "A Comparison of the Pharmacodynamic Effects of Inhaled Insulin versus Subcutaneous Insulin in Type 1 Diabetic Patients." Mark Kipnes, Babatunde Otulana, Per Clauson, Jerome Fischer, Stephen J Farr, Vibeke Hatorp, Sherwyn Schwartz, Hayward, CA. Diabetes, A Journal of the American Diabetes Association, Abstract Book, 59th Scientific Sessions, May 1999, Volume 48, Supplement I, pp. A95.
  • "Bromocriptine (Ergosetâ) Improves Glycemic Control in Type 2 Diabetics on Insulin." Sherwyn L. Schwartz. Diabetes, A Journal of the American Diabetes Association, Abstract Book, 59th Scientific Sessions, May 1999, Volume 48, Supplement I, pp. A99.
  • "Effects of Troglitazone on HbA1c and ALT Levels in Clinical Practice." Sherwyn L. Schwartz. For presentation at the President's Poster Session and Reception, American Diabetes Association 59th Scientific Sessions, June 20, 1999, San Diego, CA.
  • "RHIGF-1 Improves Glucose Control in Insulin - Requiring Type 2 Diabetics." Sherwyn L. Schwartz, MD for rhIGF- I Co-Therapy with Insulin (RICI) Study Group.
  • "Sugar-Free Zinc Gluconate Glycine Lozenges (Cold Eeze®) Do Not Adversely Affect Glucose Control in Patients with Type 1 or Type 2 Diabetes Mellitus." Sherwyn L. Schwartz, M.D.; Jerome S. Fischer, M.D.; Mark S. Kipnes, M.D. American Journal Of Therapeutics, 1075-2765, 2001 Lippincott Williams & Wilkins pp. 006-0611.
  • Long Term Effect of Glitazones in Clinical Practice. William F. Trigoso, Jacob Vadakekalam, Sherwyn Schwartz, Jerome Fischer, Mark Kipnes, Amna Salhin, Daina Dreimane, Litza Loza. San Antonio, TX. Diabetes, A Journal of The American Diabetes Association, Abstract Book, 62nd Scientific Sessions, June 14 - 18, 2002, Volume 51, Supplement 2.
  • "Effects of Simvastatin on the Lipid Profile and Attainment of Low Density Lipoprotein Cholesterol Goals When Added to Thiazolidinedione Therapy in Patients with Type 2 Diabetes Mellitus: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial." Andrew J. Lewin, MDı, Mark S. Kipnes, MD², Luigi F. Meneghini, MD³, Diane J. Plotkin, Inna T. Perevozskaya, PhD, Yale B. Mitchel, MD, Darbie L. Maccubbin, PhD, Sukrut Shah, PhD, Jonathan A. Tolbert, MD Simvastatin/Thiazolidinedione Study Group*. Clinical Therapeutics / Vol. 26, No. 3, 2004.
  • "Control of Postprandial Plasma Glucose by an Oral Insulin Product (HIM2) in Patients With Type 2 Diabetes". Mark S. Kipnes, MD¹; Paresh Dandona, MD²; Devjit Tripathy; MD²; J. Gordon Still, PhD³.; Gordana Kosutic, MD³. Diabetes Care Volume 26, Number 2, February 2003, pp:421-426, 2003.
  • "Pioglitazone Hydrochloride in Combination with Sulfonylurea Therapy Improves Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Study." Mark S. Kipnes, et al., published in The American Journal of Medicine, July 2001, Volume 111, Number 1, published by Elsevier Science.
  • "Effects of Short -Term Insulin Therapy upon Therapeutic Response to Glipizide". Schwartz, Sherwyn, MD; Fischer, Jerome S., MD; Kipnes, Mark S., MD and Boyle, Mary RN. The American Journal of Medicine, September 18, 1987, Volume 83, Supplement 3A, pp. 22 - 30.
  • "Comparing The Efficacy And Tolerability of Metformin XT QD to Immediate-Release Metformin BIDD in Patients With Type 2 Diabetes". AACE 2004 as a poster presentation. Mark S. Kipnes, MDı, Prachi K. Drandekar, Pharm.D.² Andrx Labs, Inc., 411 Hackensack Ave., Hackensack, New Jersey 07601, U.S.A.
  • "Comparison of Extended-Release Metformin with the Evening Meal to Immediate-Release Metformin bid in Type 2 Diabetes". Mark S, Kipnes, MDı, Prachi K. Drandekar, Pharm.D.². Friday, April 30, 2004 from 9:45 to 10:30 a.m. Andrx Labs., Inc., 411 Hackensack Ave., Hackensack, New Jersey 07601, U.S.A.
  • "Efficacy and Safety of Treatment With Simvastatin in Thiazolidinedione-Treated Type 2 Diabetic Patients." M. S. Kipnes, A. J. Lewin, L. F. Meneghini, I. Perevozskaya, S. Shah, D. Plotkin, J. Tobert; Merck Research Laboratories, Rahway, NJ. European Association for the Study of Diabetes (EASD2002). March 29, 2002.
  • "Durability of Glycemic Control with Pioglitazone in Long-Term Combination and Monotherapy". Daniel Einhorn, Mark Kipnes, N. Bradley Glazer, William Wishner, Pioglitazone Study Group. Diabetes, A Journal of The American Diabetes Association, Abstract Book, 61st Scientific Sessions, Monday, June 25, 2001. Volume 50, Supplement 2.
  • "Nighttime versus Fulltime Use Of An Open Loop Insulin Delivery System In Type 1 Diabetes Mellitus." Danney MM. Submitted to the 17th Annual Uniformed Services Pediatric Seminar, March 1982.
  • "Effect of Mitemcinal Fumarate (GM-611) on Gastric Emptying, Safety and Tolerability With Diabetic or Idiopathic Gastroparesis." Endo 2004 Meeting for poster presentation. Friday, June 18, 2004, 11:00 to 12:00 & 2:30 p.m. to 3:30 p.m., Exhibit Hall, poster Board #P3-577. Chugai Pharma.
  • "Safety of Mitemcinal Fumarate (GM-611) in Patients With Symptomatic Gastroparesis." A.D.A. 2004 as a poster presentation. Saturday, June 5, 2004, 12:15 p.m. to 2:15 p.m. & 5:00 p.m. to 6:00 p.m. Chugai Pharma.
  • "Effect of Mitemcinal Fumarate (GM-611) on Gastric Emptying in Patients With Idiopathic Or Diabetic Gastroparesis." Digestive Disease Week (DDW) 2004 meeting for a AGA Poster Session in May. Tuesday, May 18, 2004, Abstract ID#: 103158, Poster Session ID#: 1817, Session Type: Gastric Motility and Sensation. 12:00 to 2:00 p.m.
  • "Comparing The Efficacy And Tolerability of Metformin XT QD to Immediate-Release Metformin BIDD in Patients With Type 2 Diabetes." AACE 2004 as a poster presentation. Mark S. Kipnes, MDı, Prachi K. Drandekar, Pharm.D.². Friday, April 30, 2004 from 9:45 to 10:30 a.m. Andrx Labs, Inc., 411 Hackensack Ave., Hackensack, New Jersey 07601, U.S.A.
  • "Comparison of Extended-Release Metformin with the Evening Meal to Immediate-Release Metformin bid in Type 2 Diabetes." Mark S, Kipnes, MDı, Prachi K. Drandekar, Pharm.D.². Friday, April 30, 2004 from 9:45 to 10:30 a.m. Andrx Labs., Inc., 411 Hackensack Ave., Hackensack, New Jersey 07601, U.S.A.
  • "Plasma Glucose and Insulin Response to Isocaloric Amounts of Enteral Formulas in Persons with Type 2 Diabetes Mellitus." S.L. Schwartz, M.D.; J. Fischer, M.D.; M. Kipnes, M.D. and L. Kelly, R.N. Diabetes and Glandular Disease Research Center, San Antonio, TX. Currently used by Norvartis Nutritional, in their brochures and on their Website. January, 2003.
  • "Efficacy and Safety of Treatment With Simvastatin in Thiazolidinedione-Treated Type 2 Diabetic Patients." M. S. Kipnes¹, A. J. Lewin², L. F. Meneghini³, I. Perevozskaya4, S. Shah4, D. Plotkin, J. Tobert4.

    ¹Diabetes & Glandular Disease Research Associates, P.A., San Antonio, TX, ²National Research Institute, Los Angeles, CA, ³University of Miami School of Medicine Diabetes Research Institute, Miami, FL, 4Merck Research Laboratories, Rahway, NJ. European Association for the Study of Diabetes (EASD2002). March 29, 2002.

  • "Durability of Glycemic Control with Pioglitazone in Long-Term Combination and Monotherapy." Daniel Einhorn, Mark Kipnes, N. Bradley Glazer, William Wishner, Pioglitazone Study Group. San Diego CA; San Antonio, TX; Lincolnshire, IL. Diabetes, A Journal of The American Diabetes Association, Abstract Book, 61st Scientific Sessions, Monday, June 25, 2001. Volume 50, Supplement 2.
  • "Community Screening for Diabetes: Should Demographics be a Factor?" Mark S. Kipnes, Sherwyn L. Schwartz, Jerome S. Fischer, William F. Trigoso, Amna A. Salhin, Jacob Vadakekalam, Daina Dreimane, William D. Linn. American Association of Clinical Endocrinologists 10th Annual Meeting & Clinical Congress. May 2-6, 2001. San Antonio, Texas.
  • "Pioglitazone Hydrochloride in Combination with Metformin in the Treatment of Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Study." Daniel Einhorn MD¹, Marc Rendell, MD², James Rosenzweig, MD³, John W. Egan,4 Annette L. Mathisen, PhD4 and Roberta L. Schneider, MD4, for the Pioglitazone 027 Study Group*

    ¹Diabetes and Endocrine Associates and Sharp HealthCare, San Diego, California, ²Creighton Diabetes Center, Omaha, Nebraska, and the Rose Salter Medical Research Foundation, Baltimore, Maryland, ³Joslin Diabetes Center, Boston, Massachusetts, and 4Takeda America Research and Development Center, Inc, Princeton, New Jersey. Clinical Therapeutics. 2000;22:1395-1409. Parts of this work were presented at the 59th Annual Meeting and Scientific Sessions of the American Diabetes Association, June 19-20, 1999, San Diego, California, and published as an abstract in Diabetes, Supplement 1, May 1999. *Members of the Pioglitazone 027 Study Group are listed in the Acknowledgements. *Mark S. Kipnes: Part of 027 the Study Group.

  • "A Comparison of the Pharmacodynamic Effects of Inhaled Insulin versus Subcutaneous Insulin in Type 1 Diabetic Patients." Mark Kipnes, Babatunde Otulana, Per Clauson, Jerome Fischer, Stephen J. Farr, Vibeke Hatorp, Sherwyn Schwartz, Hayward, CA. Diabetes, A Journal of the American Diabetes Association, Abstract Book, 59th Scientific Sessions, May 1999, Volume 48, Supplement I, pp. A95.
*M.S. Kipnes - member of study group
return to top
home    current research    study opportunities    healthy living    about dgd research    contact    site map
Copyright © 2008.    dgd Research, Inc.   All rights reserved. web site design by monkee-boy | austin, texas